Cerebras CS-2 System Awarded ‘Best in Show’ at Bio-IT World Conference & Expo.
Customers around the world use CS-2 to accelerate medical breakthroughs.
SUNNYVALE, Calif – Cerebras Systems, the pioneer in high-performance artificial intelligence (AI) computing, received Bio-IT World Conference & Expo’s Best in Show award for the Cerebras CS-2 system, the world’s fastest AI solution. At the conference, Cerebras also announced biopharmaceutical leader AbbVie as a customer, achieving 128 times the performance of a graphics processing unit (GPU) on a single CS-2.
From the pharmaceutical industry, to the energy space, to U.S. national laboratories, Cerebras customers have published CS-2 performance results in excess of 100s GPUs. But the CS-2 is set up and programmed in minutes, while clusters of GPUs take weeks or months. This means less time is spent in set up and configuration, less time is spent training models and more ideas are explored.
“At Cerebras Systems, our goal is to enable AI that accelerates our customers’ missions,” said Andrew Feldman, CEO and co-founder of Cerebras Systems. “We’re proud that the judges at the Bio-IT conference recognized the CS-2 as Best in Show. And we are even more proud that customers on three continents, including AbbVie, GlaxoSmithKline, AstraZeneca, TotalEnergies and many more, are accelerating their AI-driven work. When Cerebras helps scientists find cures for disease more quickly, or scientists identify more efficient energy sources, our goals as a company are realized.”
The industry-leading CS-2 is powered by the largest processor ever built – the Cerebras Wafer-Scale Engine 2 (WSE-2). The WSE-2 is 56 times larger than the nearest competitor, contains more than 100 times the number of compute cores, more than 1000 times the amount of high-speed on-chip memory, and more than 10,000 times more memory bandwidth than the graphics processing unit. As a result, the CS-2 delivers more AI performance than any chip on the market. Purpose-built to accelerate deep learning workloads and reduce the time to answer by orders of magnitude, the CS-2 is the preferred choice among pioneering researchers the world over.
With customers and partners in North America, Asia, Europe, and the Middle East, Cerebras is delivering industry-leading AI solutions to a growing roster of customers in the enterprise, government, and high-performance computing segments including AbbVie, GlaxoSmithKline, AstraZeneca, TotalEnergies, nference, Argonne National Laboratory, Lawrence Livermore National Laboratory, Pittsburgh Supercomputing Center, Edinburgh Parallel Computing Centre (EPCC), the National Energy Technology Laboratory, and Tokyo Electron Devices.